HIV-ASSIST: A New Tool to Guide Evidence-Based Selection of Antiretroviral Therapy

In these slides, expert faculty introduce the HIV-ASSIST decision support tool and demonstrate its use in clinical decision-making.

person default
Jonathan Li, MD
Maunank Shah, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 5.25 MB
Released: February 4, 2021


Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Produced in collaboration with
Educational grant provided by:
Gilead Sciences, Inc.
Theratechnologies Inc.
ViiV Healthcare

Related Content

Slides from CCO: Switching ART in HIV: 3-drug therapy, oral 2-drug options, long-acting injectable 2-drug regimens, single tablet regimens (STRs)

Daniel R. Kuritzkes, MD Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Released: June 7, 2021

Slides from Daniel Kuritzkes and CCO. Switching to long-acting cabotegravir: ATLAS and FLAIR data, starting, dosing regimens, avoiding treatment failure

Daniel R. Kuritzkes, MD Released: June 4, 2021

Drs Roger Bedimo, Princy N. Kumar, and Brian Wood, answer commonly asked questions on managing heavily treatment-experienced patients with HIV

Roger Bedimo, MD, MS, FACP Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Released: June 2, 2021

Free expert slides from Clinical Care Options (CCO) reviewing the use of HIV-ASSIST to guide ART in a treatment-experienced patient with comorbidities

Ethel D. Weld, MD, PhD Released: May 27, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.